July 2024

July 3, 2024

Coming Soon: PrE1702 Real-World Data Study for Patients with EGFR-Mutated Non-Small Cell Lung Cancer Not Enrolled in Clinical Trials

This innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial
July 3, 2024

Amended Trial: Nataliya Uboha Gives an Update on the EA2183 Trial for Patients with Esophageal and Gastric Adenocarcinoma

The changes broaden eligibility for patients and permit more therapeutic options once enrolled in this randomized phase 3 trial, which explores the addition of radiotherapy to the usual treatment (chemotherapy) in people with esophagus and stomach cancer with limited spread